Cornea, Cataract and Refractive Surgeon
Universidad del Rosario, USA
Prof. Salomon Esquenazi has received his MD in Universidad del Rosario in Colombia during the period of 1979 to 1985. Later he underwent a residency in ophthalmology and fellowship in cornea, refractive surgery and external diseases at Louisiana State University Health Sciences Center in New Orleans, LA. Currently, he is working as cornea specialist at South Florida Eye Associates and Assistant Professor of Ophthalmology and Neuroscience Research in Louisiana State University. He is serving as reviewer for several peer-reviewed journals. He has authored almost 50 research articles/books. He is a member of American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American Society of Cataract and Refractive Surgery. He has honored as chief resident at Clinica Barraquer in Colombia in 1988 and chief resident at Louisiana State University in 2004. Additionally he was distinguished with diploma as best medical student and best intern at Universidad del Rosario in Colombia in 1985.
Corneal wound healing after refractive surgery, dry eye and tissue adhesives.
M.V. Raghavendra Rao
Professor & Head Microbiology, Department and Dean (Students affairs)
Avalon University, Netherlands
Dr. Rao, Ph.D, worked as professor of Microbiology, Parasitology, Immunology and Epidemiology in many universities, many medical colleges in India, China, Nepal, Libya, and Philippines. Currently he is working as professor of Microbiology, Parasitology, Immunology and Dean (Student Affairs) at Avalon University School of Medicine, Curacao, Netherland Antilles. Dr. Rao has more than 42 years of teaching and research experience. Supervised 3 students for Ph.D, 4 students for M.Phil, 4 students for pre M.Phil degrees. 3 students submitted their Ph.D thesis to Acharya Nagarjuna University, Guntur, Andhra Pradesh, India and waiting for viva examination and degree. Authored 18 text books. 3 Universities appointed as their adviser and 3 universities honored with fellow ships. Presented 8 full length papers exclusively during 2014 to 2015 in different international journals.In 2016 ,January and February presented two full length papers in international journals .Accepted as organizing committee member for 3 international conferences in 2016 and Invited speaker for 8 conferences, in different countries like Manchester,(UK), Birmingham,(UK), Atlanta (US), Dubai,(UAE),Rome,(Italy),Amsterdam(Netherland) etc.
Parasitology, Microbiology,Biotechnology Virology,Molecular immuno diagnostics, Public health, and epidemiology .Parasitic infections are more in tropical countries and cause global health problem especially in developing countries. High level innovation centered on genomics, RNA biology,Systemic biology, Stem cell biology,Nano science, novel animal models , strategic focus is on technology development in the ares of bio therapeutics , bio markers,bio sensors, bioequipments implants devices , advanced diagnostics, tests, vaccines, therapeutics and development of new drugs are needed. Viviparity is common among est mammals but not many provide long gestation period, To study long term parasitic toxic effects, it is essential to use long gestation period laboratory animal models. Rats have 21 days, rabbits 30,dog 60 days of gestation period, The subtle effects of Thalidomide tragedy resulting in phocomalia, apoda etc in the offspring lead to untold miseries, Similarly good number of cases of fetal deaths, still births, teratogenices etc. Dr.Rao used scorpion as research model as it has nearly 10 months gestation period , in estimation of heavy metals like mercury and lead in embryonic development of scorpion and noticed similar effects, Indeed great challenges, given that most drugs in pipe line failed in clinical trails. Because most of the drugs tested on low gestation period animals, A new thought in the drug design for parasitic diseases by using scorpion as a medical research model. Introducing parasite in scorpion and observing the drug effects and reversal effects . In addition to clinical work, developed a variety of basic and transnational research programs, participated to Ph.D. programs.
Gunma University Graduate School of Medicine, Japan
After graduating Gunma University School of Medicine and registration as MD in 1999, Koichi Sakakura, MD, PhD had trained in Department of Otolaryngology-Head and Neck Surgery, Gunma University Hospital and its affiliated hospital for 2 years as a resident doctor. In Gunma University Graduate School of Medicine, he started his carrier as a physician scientist in the field of otology (pediatric acute otitis media and equilibrium) and published 3 scientific paper. Then his research interest shifted to oncology, especially to cancer immunology. Under the guidance of his mentor Dr. K. Chikamatsu, Dr. Sakakura earned PhD degree in 2005. He had served as a clinical fellow in the department in the university hospital for 2 more years. Until 2007, he had published several articles about cancer immunology with Dr. Chikamatsu in patients with head and neck cancer (HNC): dendritic cells (DC) and NK cells in sentinel lymph nodes, DC maturation and T-cell subsets in circulation of HNC patients, induction of p53 antigen-specific immune response by cytotoxic T cell (CTL) from HNC patients, and immunological characteristics of cancer stem cell. Dr. Sakakura moved to University of Pittsburgh Cancer Institute (UPCI), PA, USA in 2007, worked in Drs. T.L. Whiteside’s and A.B. DeLeo’s labs, and involved in T-cell apoptosis by microvesicles form cancer cells and induction of MAGE-3/CSPG4-specific CTL by DC vaccine. Then he transferred to Drs. S. Ferrone’s and X. Wang’s lab in UPCI to engage in development of monoclonal antibodies against HLA class II antigen machinery molecules, and in immunohistochemical analyses of tumor antigen CSPG4 in various malignancies. He was named as a co-author in various high impact journals as Journal of National Cancer Institute and Cancer Research, and had stayed for 3 years in UPCI until 2010. He returned to Japan as a chief surgeon of otolaryngology-head and neck surgery in National Hospital Organization Shizuoka Medical Center, and awarded Grant-in Aid for Young Scientist from the Ministry of Education, Culture, Sports, Science and Technology for the development of cancer immunotherapy utilizing antigen presentation by autophagy. Dr. Sakakura was engaged as an assistant professor in 2012, and has been as an associate professor since 2016 in Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine. His current interest in cancer immunology is dynamics of myeloid cells such as macrophages, monocytes and myeloid-derived suppressor cells in tumor microenvironments and systemic circulation in patients with HNC. He has published 40 scientific papers to date mainly in oncology area, including Laboratory Investigation and Cancer Science as a corresponding author, and was recently awarded Grant-in Aid for Scientific Research to elucidate monocyte subsets in HNC patients. In addition, he has also conducted numerous daily surgeries. His subspecialty is swallowing disorder, and he is a founder and a chief of Swallow Support Team in Gunma University Hospital. He is a member of American Association for Cancer Research, American Thyroid Association, American Head and Neck Society and Dysphagia Research Society. Additionally, he has a lot of experience of oriental medicine using Kampo drugs over 15 years.
Head and Neck Surgery